Medical News
September 3rd, 2009
The U.S. FDA warns the public that there is a potential for stolen long-acting insulin Levemir, produced by Novo Nordisk Inc, to still be active on the market. Based on the FDA’s evidence, their proof suggests that the stolen insulin was improperly stored and handled, leaving the public vulnerable to risk. Many patients have informed the FDA of adverse side effects they experienced after using a vial from the stolen group, their glucose levels were incorrectly managed.
September 1st, 2009
In an attempt to manage the evolution of digital media in the healthcare industry, Palio has joined with Zemoga (a full-service interactive agency). This partnership comes as a result of the changing technological environment as well as a result of the changes in consumer abilities and demands.
September 1st, 2009
A recent national survey revealed that a considerable minority of physicians inaccurately
thought that specific off-label uses of prescription medications had been approved by the U.S Food and Drug Administration.
September 1st, 2009
American experts are not convinced that the postponed receipt of the swine flu vaccine will derail the American government’s intention of defending their country against the virus’ recent spread.
August 19th, 2009
A recent study proclaims that patients who require a blood stem-cell transplant may be able to lessen the risk of graft-versus-host disease (GVHD - transplanted materials attack the body), thanks to ant-T-cell globulin treatment.
August 19th, 2009
The August 19 issue of the Journal of the American Medical Association details a decade-long government led effort to minimize the death rate of hospitalized heart attack patients as well as upgrade the hospital’s execution of these daily emergencies.
August 19th, 2009
A new study believes that drugs that are intended to treat cell surface molecule ERBB3, can provide a more potent way of treating colon cancer.
ERBB3 is closely associated to epidermal growth factor receptor (EGFR), drugs used to treat EFGR have proven effective at tackling various cancers, but not colon cancer. Drugs used to treat ERBB3 have proven, however, to be more successful than EGFR inhibitors at targeting colon cancer.
August 19th, 2009
A Canadian research study states that Avandia, used for the treatment of type 2 diabetes, elevates the risk of heart failure and death more so than Actos.
August 19th, 2009
A new study is looking back to ancient Chinese herbal medicine for contemporary treatment options. The Chinese herb in question referred to as “thunder god vine,” has been shown to minimize inflammation for rheumatoid arthritis patients.
August 19th, 2009
The U.S. FDA and Roche have informed healthcare practitioners that patients being treated with CellCept, have reported cases of Pure Red Cell Aplasia, also known as PRCA.
